The need for a differential diagnosis to distinguish between CMMRD, NF1 and Legius syndrome as well as mosaic NF1 has been emphasised in the revised diagnostic criteria for NF1 (Legius et al. 2021). This evidence concerns the gene NF1 and neurofibromatosis type 1.